HDU critiques NIPRO needles in letter to FDA

Home Dialyzors United members know dialysis needles—they use them several times a week. The group challenged the “substantial equivalence” determination of NIPRO needles this month for a variety of reasons in a letter to the FDA. See the NIPRO response below.

Read the full article » | Posted 05-09-2015

Related Articles

• Little Chance of Passing the Improving Access to Home Dialysis Act of 2024 (H.R. 8075) Posted 12-11-2024
• Fact Sheet: Calendar Year 2025 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule is published Posted 11-21-2024
• Is your U.S. Representative a co-sponsor for Improving Access to Home Dialysis Act of 2024 (H.R. 8075)? Posted 08-16-2024
• Bill Would Expand Medigap Access for Dialysis Patients if Passed Posted 06-14-2024